Phillip A. Sharp - Director, Alnylam Pharmaceuticals, Inc
As of July 2, 2019
Phillip A. Sharp Net Worth
- Net worth is estimated to be at least $287.31M
- Owns at least 266,899 units of Alnylam Pharmaceuticals, Inc stock
- Sold an estimated value of $20.25M in the last 15 years at Alnylam Pharmaceuticals, Inc
Phillip A. Sharp Trading
- Largest purchase of shares was 131,890 units , worth over $847.8K on October 15, 2014
- Largest sale of shares was 131,890 units , worth over $9.35M on October 15, 2014
- In total has made about 28 transactions over 15 years
- Usually trades in June, with the busiest year in 2017
Phillip A Sharp
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
Phillip A. Sharp Mailing Address
- Mailing address is Biogen Inc Legal Department 14 Cambridge Center Cambridge MA 02142 MA
Alnylam Pharmaceuticals, Inc Insider Trading
- The most recent transaction was 15,000 units sold on April 5, 2022 by Steven M Paul worth over $2.56M
- In the last 18 years, insiders at Alnylam Pharmaceuticals, Inc sold an estimated value of $488.87M and bought an estimated value of $246.16M
- The most active traders are John Maraganore, Chief Executive Officer, Akshay Vaishnaw, President, and Barry E Greene, President
- Insider trading is most common in June, with the busiest year in 2014
POLARIS INDUSTRIES INC/MN Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |